Brisbane Clinical Trials

The Fibrosis Study

The study drug is a potential new treatment for Systemic Sclerosis (SSc)

3 nights
6 visits

Study Objective:

  • The purpose of this study is to evaluate the efficacy of a potential new treatment for systemic sclerosis (SSc)
  • SSc is a rare, serious lung disease characterized by high blood pressure in the lungs & arteries, which can lead to heart failure if untreated.

Importance of Treatment:

  • This study aims to explore more effective options, potentially improving patient outcomes and quality of life for future generations suffering with this condition.

An independent ethics committee has approved this clinical trial.

Participants will be reimbursed for their time.

Clinical Trial Details:

Eligibility

Biological Sex Male or Female
Age 18-60 years old
BMI 18 - 32 kg/m²
Weight 50kg - 100kg
Medication Not taking any prescription medication
Smoking Non-smokers or light smokers (<5 cigarettes/week)